References
- Burchell B., Coughtrie M. W. H. UDP-glucuronosyltransferases. Pharmacology and Therapeutics 1989; 43: 261–289
- Danhof M., de Boer A. G., de Groot-van DER Vis E., Breimer D. D. Studies on the different metabolic pathways of antipyrine in rats: influence of phenobarbital and 3-methylcholan-threne treatment. Xenobiotica 1979; 9: 695–702
- Danhof M., van Zuilen A., Boeijinaga J. K., Breimer D. D. Studies on different metabolic pathways of antipyrine in man. Oral versus intravenous administration and the influence of urinary collection time. European Journal of Clinical Pharmacology 1982; 21: 433–441
- Tanaka E., Kinoshita H., Yoshida T., Kuroiwa Y. Determination of plasma trimethadione and its metabolite in carbon tetrachloride-intoxicated rat liver: a useful tool for estimation of hepatic drug-metabolizing capacity. Journal of Pharmacobio-Dynamics 1981; 4: 961–967
- Tanaka E., Kinoshita H., Yoshida T., Kuroiwa Y. Trimethadione as a model drug for the evaluation of hepatic drug-metabolizing capacity in normal and α-naphthylisothiocyanate intoxicated rats. Pharmacology 1982a; 25: 202–209
- Tanaka E., Kinoshita H., Yoshida T., Kuroiwa Y. Trimethadione as a model drug for the evaluation of hepatic drug-metabolizing capacity in normal and d-Galactosamine intoxicated rats. Japanese Journal of Pharmacology 1982b; 32: 1182–1185
- Teunissen M. W. E., Meerburg-van DER Torren J. E., Vermeulen N. P. E., Breimer D. D. Automated HPLC-determination of antipyrine and its main metabolites in plasma, saliva and urine, indluding 4,4′-dihydroxyantipyrine. Journal of Chromatography 1983; 278: 367–378
- Teunissen M. W. E. Factors and conditions affecting antipyrine clearance and metabolite formation. Thesis, 1984
- Vesell E. S. The antipyrine test in clinical pharmacology: conceptions and misconceptions. Clinical Pharmacology and Therapeutics 1979; 26: 275–286
- Watkins J. B., Gregus Z., Thompson T. N., Klaassen C. D. Induction studies on the functional heterogeneity of rat liver UDP-glucuronosyltransferases. Toxicology and Applied Pharmacology 1982; 64: 439–446